发明名称 |
Captodiamine for the treatment of depression symptoms |
摘要 |
<p>The invention provides a selective Sigma 1 or Dopamine D3 receptor agonist or a 5HT2c receptor ligand for use in the treatment of symptoms of anxiety and/or depression associated with an affective disorder and/or symptoms associated with cognitive impairment disorder. Particularly useful are diphenhydramine derivatives of Formula (I) and particularly (2-[(4-butylsulfanylphenyl)-phenyl-methyl]sulfanyl-N,N-dimethyl-ethanamin) (Captodiamine).</p> |
申请公布号 |
EP2291181(B9) |
申请公布日期 |
2013.09.11 |
申请号 |
EP20090732103 |
申请日期 |
2009.04.20 |
申请人 |
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND, DUBLIN |
发明人 |
REGAN, CIARAN;CONBOY, LISA;GANNON, SHANE |
分类号 |
A61K31/137;A61P25/24;A61P25/28 |
主分类号 |
A61K31/137 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|